Evolus EOLS
NASDAQ EOLS
$8.35 -0.25 (-2.91%)
At close: Aug 20, 2026 · 2:59 PM UTC

Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026)

Evolus' (EOLS) quarterly Depreciation & Amortization (CF) came in at $2.3 million in Q1 2026, up 50.1% YoY from $1.6 million in Q1 2025, and up 4.08% on a QoQ basis from $2.3 million in Q4 2025.

Evolus (EOLS) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Evolus (EOLS) has 10 years of Depreciation & Amortization (CF) data on file, last reported at $2.3 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 50.1% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (up 52.06% YoY) and the FY2025 annual result came in at $7.5 million, up 41.7% from the prior year.
  • Depreciation & Amortization (CF) grew to $2.3 million in Q1 2026, from $2.3 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $2.3 million in Q1 2026 to a low of $853000.0 in Q2 2022.
  • A 5-year average of $1.4 million and a median of $1.4 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) tumbled 54.65% — and 2025, when it jumped 79.48%.
  • Tracing EOLS's Depreciation & Amortization (CF) over 5 years: stood at $1.0 million in 2022, then jumped by 33.69% to $1.4 million in 2023, then increased by 0.07% to $1.4 million in 2024, then soared by 64.05% to $2.3 million in 2025, then advanced by 4.08% to $2.3 million in 2026.
  • The last three Depreciation & Amortization (CF) figures came in at $2.3 million (Q1 2026), $2.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn 241.00 Mn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 119.00 Mn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 1.02 Bn
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn 24.20 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 672.30 Mn
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 171.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Evolus 550.51 Mn 505.34 Mn 57.18 Mn 2.34 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 2.34 Mn
Jun 30, 2026 2.34 Mn
Mar 31, 2026 2.35 Mn
Mar 31, 2026 2.35 Mn
Dec 31, 2025 2.25 Mn
Dec 31, 2025 2.25 Mn
Sep 30, 2025 1.95 Mn
Sep 30, 2025 1.95 Mn
Jun 30, 2025 1.74 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 1.56 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 1.37 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.09 Mn
Sep 30, 2024 1.09 Mn
Jun 30, 2024 1.43 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 1.41 Mn
Mar 31, 2024 1.41 Mn